K
Keiko Shiratori
Researcher at Mitsubishi Tanabe Pharma
Publications - 170
Citations - 6651
Keiko Shiratori is an academic researcher from Mitsubishi Tanabe Pharma. The author has contributed to research in topics: Autoimmune pancreatitis & Pancreatitis. The author has an hindex of 36, co-authored 167 publications receiving 6134 citations.
Papers
More filters
Journal ArticleDOI
Chronic pancreatitis caused by an autoimmune abnormality : proposal of the concept of autoimmune pancreatitis
Kenji Yoshida,Fumitake Toki,Tadashi Takeuchi,Shin-ichiro Watanabe,Keiko Shiratori,Naoaki Hayashi +5 more
TL;DR: In this paper, the authors reported a case of chronic pancreatitis in which an autoimmune mechanism is involved in the etiology and summarized the cases of pancreatitis suspected of being caused by an auto-antibody-positive mechanism in the Japanese and English literature.
Journal ArticleDOI
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal.
Kazuichi Okazaki,Shigeyuki Kawa,Terumi Kamisawa,Satoru Naruse,Shigeki Tanaka,Isao Nishimori,Hirotaka Ohara,Tetsuhide Ito,Seiki Kiriyama,Inui K,Tooru Shimosegawa,Masaru Koizumi,Koichi Suda,Keiko Shiratori,Koji Yamaguchi,Taketo Yamaguchi,Masanori Sugiyama,Makoto Otsuki +17 more
TL;DR: The accumulation of many AIP cases shows that the concept of AIP has changed slightly to include extrapancreatic lesions and associated disorders, which suggests that the current diagnostic criteria are becoming inadequate.
Journal ArticleDOI
Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas
Toru Furukawa,Yuko Kuboki,Etsuko Tanji,Shoko Yoshida,Takashi Hatori,Masakazu Yamamoto,Noriyuki Shibata,Kyoko Shimizu,Naoyuki Kamatani,Keiko Shiratori +9 more
TL;DR: Results indicate that GNAS mutations are common and specific for IPMN, and activation of G-protein signaling appears to play a pivotal role in IPMN.
Journal ArticleDOI
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Etsuko Hashimoto,Satoru Yatsuji,Maki Tobari,Makiko Taniai,Nobuyuki Torii,Katsutoshi Tokushige,Keiko Shiratori +6 more
TL;DR: It is confirmed that older age and advanced fibrosis were important risk factors for HCC, and that HCC was the major cause of mortality in NASH patients withadvanced fibrosis.
Journal ArticleDOI
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.
Satoru Yatsuji,Etsuko Hashimoto,Maki Tobari,Makiko Taniai,Katsutoshi Tokushige,Keiko Shiratori +5 more
TL;DR: This work compared cirrhotic NASH with liver cirrhosis caused by chronic hepatitis C (LC‐C) to clarify its clinical features and define the risk factors for death.